FDA approves first mRNA flu vaccine in the United States

The US Food and Drug Administration (FDA) has approved the first mRNA-based influenza vaccine in the United States. The decision marks a significant expansion of mRNA vaccine technology, which was previously used primarily in COVID-19 vaccines, into seasonal flu prevention.